# A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b

> **NCT02585752** · NA · TERMINATED · sponsor: **ResMed** · enrollment: 20 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DEVICE:** Noninvasive ventilation

## Key facts

- **NCT ID:** NCT02585752
- **Lead sponsor:** ResMed
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10-01
- **Primary completion:** 2017-09-30
- **Final completion:** 2017-11-24
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2018-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02585752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02585752, "A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02585752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*